Cargando…
Bioevaluation of Pheretima vulgaris Antithrombotic Extract, PvQ, and Isolation, Identification of Six Novel PvQ-Derived Fibrinolytic Proteases
Thrombosis is a disease that seriously endangers human health, with a high rate of mortality and disability. However, current treatments with thrombolytic drugs (such as recombinant tissue-plasminogen activator) and the oral anticoagulants (such as dabigatran and rivaroxaban) are reported to have a...
Autores principales: | Yang, Wanqing, Wang, Wenjie, Ma, Yunnan, Yang, Qilin, Li, Pengyue, Du, Shouying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402109/ https://www.ncbi.nlm.nih.gov/pubmed/34443534 http://dx.doi.org/10.3390/molecules26164946 |
Ejemplares similares
-
A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation
por: Liu, Hai, et al.
Publicado: (2022) -
Characterizing a standardized BioPart for PVQ-specific expression in
C. elegans
por: AlHarbi, Sarah, et al.
Publicado: (2023) -
Bioevaluation and Targeted Modification of Temporin-FL From the Skin Secretion of Dark-Spotted Frog (Pelophylax nigromaculatus)
por: Wang, Wenjie, et al.
Publicado: (2021) -
The Phaseolus vulgaris Receptor-Like Kinase PvFER1 and the Small Peptides PvRALF1 and PvRALF6 Regulate Nodule Number as a Function of Nitrate Availability
por: Solís-Miranda, Jorge, et al.
Publicado: (2023) -
An Integrated Strategy of Chemical Fingerprint and Network Pharmacology for the Discovery of Efficacy-Related Q-Markers of Pheretima
por: Shang, Ye, et al.
Publicado: (2022)